Wednesday 11th June 2025, the Government delivered their Spending Review, providing insight into the UK Government's plans ...

An NHS project in mid and south Essex is making it easier for people with dementia in care homes to get dental treatment. John Murphy, who has dementia, is one of over 5,000 care home residents to ...

This Dementia Action Week, 19 - 25 May 2025, we will continue to raise awareness of the importance of an early diagnosis for people affected by dementia. Diagnosis is vital to give people access to ...

At Alzheimer’s Society, we're now a proud partner in a £6 million initiative funded by UK Research and Innovation (UKRI) and the National Institute for Health and Care Research (NIHR) to develop ...

There are ways to support a person with dementia when travelling. These will depend on the type of transport being used. People with dementia can have difficulties with planning and remembering the ...

Metformin is a common diabetes type 2 medication, which has been shown by previous research to have both good and bad effects when used as a potential treatment for Alzheimer’s disease. This research ...

In July 2024, Alzheimer’s Society launched the Dementia Healthcare Inequalities Initiative. We sat down with Professor Jennie Popay, the Chair of our Healthcare Inequalities Advisory Board to hear ...

Today the dementia diagnosis rate target (that 66.7% of people living with dementia in England should have a diagnosis) has been removed from the NHS Operational Planning Guidance for 2025-6. Fiona ...

Today we launched a powerful new campaign that sheds light on the hidden reality of dementia and the devastating impact a lack of support has on thousands of families. We want to kickstart a national ...

There are many reasons why a person with dementia may need to move to a new care home. For example, their care home may be closing or their dementia may have progressed, so they need more specialist ...

This World Alzheimer’s Month, we have published new data revealing that people living with undiagnosed dementia attend A&E three times more than those without the condition, accounting for more than ...

The MHRA have approved lecanemab for some people with early-stage Alzheimer’s disease. However NICE does not recommend use on the NHS for any patients. Fiona Carragher, Chief Policy and Research ...